Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
Recent findings in HIV/AIDS described by K. Babaahmady and colleagues
September 10th, 2008
In this recent study, researchers in London, the United Kingdom conducted a study "To elicit broadly neutralizing antibody activity by combining polyclonal human serum IgG antibodies with HIVgp120, human leukocyte antigen (HLA) class I or class II and 70kDa heat shock protein. In addition to HIV antigens, HIV-1 virions express HLA class I, HLA class II and 70kDa heat shock protein molecules, which have quantitative and functional significance." "The complementary effect of combining human polyclonal IgG antibodies with these antigens may result in effective broad spectrum neutralizing activity. Polyclonal human sera with IgG antibodies and monoclonal antibody to HLA...
Source: Vaccine Weekly (2008-09-10)
|
